1. Home
  2. ATAI vs ANGO Comparison

ATAI vs ANGO Comparison

Compare ATAI & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • ANGO
  • Stock Information
  • Founded
  • ATAI 2018
  • ANGO 1988
  • Country
  • ATAI Germany
  • ANGO United States
  • Employees
  • ATAI N/A
  • ANGO N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • ANGO Medical/Dental Instruments
  • Sector
  • ATAI Health Care
  • ANGO Health Care
  • Exchange
  • ATAI Nasdaq
  • ANGO Nasdaq
  • Market Cap
  • ATAI 282.6M
  • ANGO 439.5M
  • IPO Year
  • ATAI 2021
  • ANGO 2004
  • Fundamental
  • Price
  • ATAI $1.41
  • ANGO $9.28
  • Analyst Decision
  • ATAI Strong Buy
  • ANGO Strong Buy
  • Analyst Count
  • ATAI 3
  • ANGO 2
  • Target Price
  • ATAI $10.50
  • ANGO $14.00
  • AVG Volume (30 Days)
  • ATAI 1.4M
  • ANGO 330.5K
  • Earning Date
  • ATAI 05-19-2025
  • ANGO 04-02-2025
  • Dividend Yield
  • ATAI N/A
  • ANGO N/A
  • EPS Growth
  • ATAI N/A
  • ANGO N/A
  • EPS
  • ATAI N/A
  • ANGO N/A
  • Revenue
  • ATAI $308,000.00
  • ANGO $283,320,000.00
  • Revenue This Year
  • ATAI $65.58
  • ANGO N/A
  • Revenue Next Year
  • ATAI N/A
  • ANGO $6.35
  • P/E Ratio
  • ATAI N/A
  • ANGO N/A
  • Revenue Growth
  • ATAI N/A
  • ANGO N/A
  • 52 Week Low
  • ATAI $1.03
  • ANGO $5.47
  • 52 Week High
  • ATAI $2.57
  • ANGO $13.50
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 44.57
  • ANGO 48.87
  • Support Level
  • ATAI $1.36
  • ANGO $8.55
  • Resistance Level
  • ATAI $1.54
  • ANGO $9.61
  • Average True Range (ATR)
  • ATAI 0.09
  • ANGO 0.36
  • MACD
  • ATAI -0.00
  • ANGO -0.04
  • Stochastic Oscillator
  • ATAI 0.00
  • ANGO 60.33

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Share on Social Networks: